Call to end paying for Alzheimer's care
27/06/2008
Counsel and Care, the national charity getting the best care and support for older people, their families and carers, today gives its support to the Alzheimer’s Society’s new report The Dementia Tax - Charging for people with dementia for inadequate care: the evidence for change.
More Stories
Alzheimers: the message for all of us from Terry Pratchett's experience
Best selling author Terry Pratchett has put the plight of hundreds of thousands of Alzheimer's sufferers in the spotlight. Here one reader, who cared for her mother when she had the disease, asks why it is such a poor relation when it comes to support.
How to choose a care home for dementia sufferers
Care staff in nursing homes receive no compulsory training in dementia – a condition affecting two thirds of all care home residents. The findings come as Alzheimer’s Society releases a new guide to choosing a care home.
Alzheimer's charity condemns anti-psychotic drugs
The NHS is wasting as much as £80 million a year on prescribing unnecessary sedative drug treatments to people with dementia, according to the Alzheimer's Society.
Educated people who develop dementia lose their memory faster
Startling new research has shown that people with more years of education lose their memory faster than those with less education in the years prior to a diagnosis of dementia. Whilst higher levels of education delay the onset of dementia, once it begins, the memory loss is around 4% faster.
Alzheimer's decision: "is this the sort of society we want to live in?"
The High Court has upheld the National Institute for Health and Clinical Excellence (NICE) decision not to recommend drugs for early-stage Alzhiemer’s Disease, drawing sharp criticism from campaigners. "NICE failed to listen to the views of thousands of carers who told them drug treatments make a huge difference to their lives," they say. By Mature Times editor Tony Watts.
Decision today on Alzheimer's treatment
A verdict is due today on the first-ever challenge of a decision by the National Institute for Health and Clinical Excellence (NICE). The result of the unprecedented judicial review follows a two-year campaign to secure access to the only drug treatments for people in the early stages of Alzheimer’s disease on the NHS.
Quality of life needs to be improved for Scotland's 58,000 dementia patients
A report published by the Mental Welfare Commission for Scotland says that hospital based care for patients with severe dementia should be driven by patient need rather than resources.
Dementia "not getting the priority it deserves"
A new report by the National Audit Office (NAO) has highlighted the fact that, despite a steeply rising trend in cases of dementia, the condition is being given too low a priority by health and social services.
Why can’t we afford the drugs needed for older people?
One measure of a country’s values is how it treats its old folk. To the shame of our politicians the UK, and England in particular, comes way down the list.
NICE makes concessions for Alzheimer's sufferers in the High Court
The legal challenge currently being mounted on behalf of Alzheimer's sufferers has won an important concession by NICE's lawyers, suggesting that doctors can prescribe the treatments even when patients fall outside the guidance.
Alzheimer campaigners have their day in court
Today, a two-year fight against the decision to restrict access to the only drug treatments for Alzheimer’s disease will arrive at the Royal Courts of Justice.
Nursing home placement can accelerate Alzheimer's
A new USA study has highlighted the benefit of adult day care programmes as a transition stage from independent living to full-time nursing home placement.
High Court fast tracks legal challenge to Alzheimer’s treatment decision
The High Court is to fast track the date for the Judicial Review hearing which will challeng the process by which the National Institute for Health and Clinical Excellence (NICE) reached its decision to ban anti-dementia medicines for NHS patients with newly diagnosed mild Alzheimer's disease.
Judge gives go ahead for Alzheimer’s challenge
The Alzheimer's Society has been given the go ahead to challenge the National Institute for Health and Clinical Excellence's (NICE) controversial ruling on Alzheimer's drug treatments in the High Court.
